Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Ipsen to acquire global oncology assets from Merrimack for $1.25bn

pharmaceutical-technologyJanuary 11, 2017

Tag: Oncology , acquisition

PharmaSources Customer Service